Patent application number | Description | Published |
20110319394 | FUSED HETEROCYCLIC COMPOUNDS - The present invention provides a compound which has the effect of PDE inhibition, and which is useful as an agent for preventing or treating schizophrenia. The compound is represented by the formula (I): | 12-29-2011 |
20130090341 | HETEROCYCLIC COMPOUNDS - The present invention provides a compound useful as an agent for the prophylaxis or treatment of neurodegenerative disease and the like, or a salt thereof. | 04-11-2013 |
20130150344 | HETEROCYCLIC COMPOUND - The present invention provides a compound represented by the formula (1): | 06-13-2013 |
20130172328 | FUSED HETEROCYCLIC COMPOUNDS AS PHOSPHODIESTERASES (PDES) INHIBITORS - The present invention provides a compound which has the effect of PDE inhibition, and which is useful as an agent for preventing or treating schizophrenia or so on represented by the formula (I): | 07-04-2013 |
20130303553 | FUSED HETEROCYCLIC COMPOUNDS - The present invention provides a compound which has the effect of PDE inhibition, and which is useful as an agent for preventing or treating schizophrenia. The compound is represented by the formula (I): | 11-14-2013 |
20130331409 | CONDENSED HETEROCYCLIC COMPOUND - The present invention provides a compound having a superior PDE10A inhibitory action and use thereof. The compound is a compound represented by the following formula (I): | 12-12-2013 |
20140088118 | HETEROCYCLIC COMPOUNDS - The present invention provides a compound useful as an agent for the prophylaxis or treatment of neurodegenerative disease and the like, or a salt thereof. | 03-27-2014 |
20140088146 | HETEROCYCLIC COMPOUNDS - The present invention provides a compound useful as an agent for the prophylaxis or treatment of neurodegenerative disease and the like, or a salt thereof. | 03-27-2014 |